Carl Zeiss Meditec AG (ETR:AFX – Get Free Report)’s share price traded up 6% on Monday . The stock traded as high as €57.10 ($59.48) and last traded at €56.30 ($58.65). 493,688 shares were traded during mid-day trading, an increase of 423% from the average session volume of 94,405 shares. The stock had previously closed at €53.10 ($55.31).
Carl Zeiss Meditec Stock Performance
The firm has a market capitalization of $5.10 billion, a PE ratio of 25.02, a price-to-earnings-growth ratio of 2.83 and a beta of 0.98. The business’s fifty day simple moving average is €51.01 and its 200-day simple moving average is €58.14. The company has a debt-to-equity ratio of 6.74, a quick ratio of 2.47 and a current ratio of 3.51.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Further Reading
- Five stocks we like better than Carl Zeiss Meditec
- Earnings Per Share Calculator: How to Calculate EPS
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- Do ETFs Pay Dividends? What You Need to Know
- 3 Steel Stocks Soaring After Tariff Announcements
- What is a buyback in stocks? A comprehensive guide for investors
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
